120 related articles for article (PubMed ID: 24368110)
1. miR-126 in human cancers: clinical roles and current perspectives.
Ebrahimi F; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Feb; 96(1):98-107. PubMed ID: 24368110
[TBL] [Abstract][Full Text] [Related]
2. miR-196, an Emerging Cancer Biomarker for Digestive Tract Cancers.
Lu YC; Chang JT; Chan EC; Chao YK; Yeh TS; Chen JS; Cheng AJ
J Cancer; 2016; 7(6):650-5. PubMed ID: 27076845
[TBL] [Abstract][Full Text] [Related]
3. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
4. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.
Fuziwara CS; Kimura ET
Int J Endocrinol; 2014; 2014():743450. PubMed ID: 25202329
[TBL] [Abstract][Full Text] [Related]
6. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
Chen H; Li L; Wang S; Lei Y; Ge Q; Lv N; Zhou X; Chen C
Oncotarget; 2014 Dec; 5(23):11873-85. PubMed ID: 25428912
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
Shibayama Y; Kondo T; Ohya H; Fujisawa S; Teshima T; Iseki K
Oncol Rep; 2015 May; 33(5):2176-82. PubMed ID: 25759982
[TBL] [Abstract][Full Text] [Related]
8. Functions of miR126 and innate immune response.
Bai Y; Lu W; Han N; Bian H; Zhu M
Yi Chuan; 2014 Jul; 36(7):631-6. PubMed ID: 25076026
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment.
Banno K; Iida M; Yanokura M; Kisu I; Iwata T; Tominaga E; Tanaka K; Aoki D
ScientificWorldJournal; 2014; 2014():178075. PubMed ID: 24516357
[TBL] [Abstract][Full Text] [Related]
10. miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin.
Yu Q; Liu SL; Wang H; Shi G; Yang P; Chen XL
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6569-72. PubMed ID: 24377569
[TBL] [Abstract][Full Text] [Related]
11. Circ_0061140 Potentiates Clear Cell Renal Cell Carcinoma Progression Via the MicroRNA-126-5p/ADAM9 Axis.
Jia G; Lv D; Ni S
Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38062234
[TBL] [Abstract][Full Text] [Related]
12. Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma.
Ivanova E; Asadullina D; Gilyazova G; Rakhimov R; Izmailov A; Pavlov V; Khusnutdinova E; Gilyazova I
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979782
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC).
Wilczyński JR; Szubert M; Paradowska E; Wilczyński M
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612107
[TBL] [Abstract][Full Text] [Related]
14. Polo-Like Kinase 2: From Principle to Practice.
Zhang C; Ni C; Lu H
Front Oncol; 2022; 12():956225. PubMed ID: 35898867
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review).
Ma RJ; Ma C; Hu K; Zhao MM; Zhang N; Sun ZG
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35856449
[TBL] [Abstract][Full Text] [Related]
16. Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target.
Leng Q; Ding J; Dai M; Liu L; Fang Q; Wang DW; Wu L; Wang Y
Front Cardiovasc Med; 2022; 9():879351. PubMed ID: 35757325
[TBL] [Abstract][Full Text] [Related]
17. miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer.
Msheik ZS; Nassar FJ; Chamandi G; Itani AR; Gadaleta E; Chalala C; Alwan N; Nasr RR
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328298
[TBL] [Abstract][Full Text] [Related]
18. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications.
Chen P; Hu J; Han X; Chen Y
Mol Biol Rep; 2022 Jun; 49(6):4929-4941. PubMed ID: 35025029
[TBL] [Abstract][Full Text] [Related]
19. Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.
Lee SM; Kaye KM; Slack FJ
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34725152
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?
Sun Y; Liu G
J Cancer; 2021; 12(22):6773-6786. PubMed ID: 34659566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
